.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Argus Health
Daiichi Sankyo
Chinese Patent Office
US Department of Justice
Express Scripts
Merck
McKesson
Fuji
Chubb

Generated: September 19, 2017

DrugPatentWatch Database Preview

Cytarabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cytarabine and what is the scope of cytarabine patent protection?

Cytarabine
is the generic ingredient in four branded drugs marketed by Teva Pharms Usa, Fresenius Kabi Usa, Mylan Labs Ltd, Mylan Pharms Inc, Pacira Pharms Inc, Hospira, West-ward Pharms Int, Teva Parenteral, and Celator Pharms, and is included in sixteen NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for cytarabine. Six suppliers are listed for this compound.

Summary for Generic Name: cytarabine

Tradenames:4
Patents:6
Applicants:9
NDAs:16
Drug Master File Entries: see list15
Suppliers / Packagers: see list6
Bulk Api Vendors: see list73
Clinical Trials: see list914
Patent Applications: see list9,938
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cytarabine at DailyMed

Pharmacology for Ingredient: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
CYTARABINE
cytarabine
INJECTABLE;INJECTION074245-001Aug 31, 1994RXNoYes► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
CYTARABINE
cytarabine
INJECTABLE;INJECTION201784-001Jan 30, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
CYTOSAR-U
cytarabine
INJECTABLE;INJECTION075206-003Dec 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
CYTARABINE
cytarabine
INJECTABLE;INJECTION071472-001Aug 2, 1989RXNoYes► Subscribe► Subscribe► Subscribe
Celator Pharms
VYXEOS
cytarabine; daunorubicin
POWDER;INTRAVENOUS209401-001Aug 3, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Hospira
CYTARABINE
cytarabine
INJECTABLE;INJECTION072168-001Aug 31, 1990APRXNoYes► Subscribe► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-004Dec 21, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Celator Pharms
VYXEOS
cytarabine; daunorubicin
POWDER;INTRAVENOUS209401-001Aug 3, 2017RXYesYes► Subscribe► Subscribe ► Subscribe
West-ward Pharms Int
CYTARABINE
cytarabine
INJECTABLE;INJECTION074245-002Aug 31, 1994RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
US Army
Harvard Business School
Teva
Chinese Patent Office
Colorcon
Federal Trade Commission
Dow
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot